The Estée Lauder Companies presented new scientific findings in skin care science at the 2026 IMCAS World Congress. 

ELC’s Dr. Rishabh Kala, Lead Scientist for Estée Lauder, and Dr. Jaime Emmetsberger, Lead Scientist for La Mer’s Max Huber Research Labs, delivered talks showcasing their brands’ skin longevity and regenerative aesthetics research, respectively.

Hosted in Paris in late January, this year’s conference drew more than 20,000 participants, bringing together the latest science from prominent leaders and the newest developments from major industry players. 

Claude Saliou, Senior Vice President, Advanced Technologies and Global Clinical & Consumer Science, ELC, said,

“We are honored to have two of our expert scientists selected to present at the 2026 IMCAS World Congress, an achievement that reflects the strength of our Global Research and Innovation organization. Their research underscores our company’s longstanding leadership in skin longevity and regenerative aesthetics, exemplifying our ability to translate cutting-edge discovery into transformative beauty innovations.”

Skin Longevity

Dr. Kala highlighted ELC’s 17-plus years of research in skin longevity, underscoring the brand’s leadership in the field. 

By supporting visible age reversal and improved skin resilience, the company is continuing to advance skin longevity, helping skin cells perform at their peak and act younger and healthier for longer.

Regenerative Aesthetics

Dr. Emmetsberger highlighted exosomes as one of the most rapidly emerging areas of interest in cosmetic science. 

Rather than treating exosomes as a single “ingredient,” she framed them as biological messengers whose impact depends on understanding them and the signals they carry. 

Building on Dr. Emmetsberger’s expertise, the company is continuing to deepen its scientific understanding of signaling vesicle platforms, like exosomes, and translating into delivering meaningful skin benefits.